https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
HIGH FREE CASH FLOW
CONVERSION
Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M)
Source: Peer data per Bloomberg market data as of February 15, 2022
86 89
85
80
76 76
89
85
79 78 76 76 76
70 69
63
8
LB
Source: Peer data per Bloomberg market data as of February 15, 2022
Total Enterprise Value / 2022E EBITDAWith the Clariant Color business
acquisition and divestment of the
PP&S business, our exposure is
now concentrated in less-cyclical
and high-growth markets.
https://www.avient.com/sites/default/files/2021-09/avnt-q2-2021-earnings-presentation.pdf
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
25
Avient reflects 2021 estimated EBITDA of $580M
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
9.5
18.5
15.1 15.1
14.0
11.0 10.4
29.5
28.2
23.9
18.7
12.4 12.2
11.1
9.3 9.2 9.2
7.6 7.6
6.0
en
t
Median: 11.1xMedian: 14.6x
SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
20
Avient reflects 2021 estimated EBITDA of $560M
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
10.2
17.7
16.0
14.9 14.6
11.6 11.1
26.7
24.0
22.8
14.3
12.7
11.5 11.2 11.1 11.0 10.3 10.1
9.5 9.4
8.3
7.0
Median: 11.1xMedian: 14.8x
SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
26
Avient reflects 2021 estimated EBITDA of $510M
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
11.3
18.6
14.3
13.6 13.3
12.2
10.7
28.8
26.3
23.3
14.6
12.4 11.7 11.6 11.2 11.0
10.6 10.3
9.6 9.1 8.5
7.2
Median: 11.2xMedian: 13.5x
SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
With the Clariant Masterbatch
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
24
Avient reflects 2021 estimated EBITDA of $510M
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
9.5
21.1
13.2 13.2
12.0 12.0
9.7
25.2
23.1
14.7
13.5 12.9
11.0 11.0 11.0 10.2
9.6 9.3 9.3 9.1 8.6 8.3
Median: 11.0xMedian: 12.6x
SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2022-02/AVNT Q4 2021 Earnings Presentation_0.pdf
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA
HIGH FREE CASH FLOW
CONVERSION
Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M)
Source: Peer data per Bloomberg market data as of February 15, 2022
86 89
85
80
76 76
89
85
79 78 76 76 76
70 69
63
8
LB
Source: Peer data per Bloomberg market data as of February 15, 2022
Total Enterprise Value / 2022E EBITDAWith the Clariant Color business
acquisition and divestment of the
PP&S business, our exposure is
now concentrated in less-cyclical
and high-growth markets.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Standard%2520Quality%2520Response_2016_6_9.pdf
Various techniques as appropriate to the
situation but generally including:
Correlation & regression analysis, pareto
charting, fish-bone diagrams, Pp/Ppk/Cpk
analysis, Control Charting, Statistical Studies of
uncertainty in test results due to process,
sampling and test variability (R&R), Uncertainty
budgeting, Round-robin testing of control
samples, proficiency testing, DFMEA & FMEA,
Control plans, Process mapping & value
stream mapping, Lean Six Sigma techniques,
5S, Formal Vendor Evaluation programs,
tracking of vendor performance, vendor audits,
customer visits, customer surveys, customer
focus groups, etc.
6.
https://www.avient.com/sites/default/files/2020-03/2020proxy.pdf
In October, we
divested our PP&S segment which consisted predominately of the legacy Geon® vinyl business for $775 million.
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
With the Clariant Color business
acquisition and divestment of the
PP&S business, our exposure is now
concentrated in less-cyclical and
high-growth markets, with increased
geographic diversification and a more
specialized portfolio that can
significantly expand EBITDA margins.
24
Avient reflects 2021 estimated EBITDA of $580M
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
11.0
18.3
16.3
15.4
14.5
11.6 11.1
36.2
28.0
24.9
13.0
11.5 11.3
10.0 9.2 8.8
7.7
6.7
en
t
SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2022-04/Avient Acquisition of Dyneema and Q1 2022 Results_0.pdf
Purchase price multiple rapidly declining on strength of
business and synergy capture
(1) Financial information is pro forma to include a full year of Clariant Color acquisition
11.9%
16.2%
2019PF 2021
EBITDA Margins
SPECIALTY TRANSFORMATION
7%
46%
66%
86%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2021 2022 PF
%
o
f A
dj
us
te
d
EB
IT
D
A(1
)
JVs Distribution Performance Products & Solutions Specialty
(1) Adjusted EBITDA is EBITDA excluding corporate costs and special items
(2) Pro forma for the acquisition of Dyneema® and potential divestiture of Distribution
(2)
29
12%
18%
16% 15% 15% 14% 14%
28% 28%
26%
25%
22% 21% 19%
16%
12%
9% 9%
Av
ie
nt
T
od
ay
Av
ie
nt
P
F
AV
Y
PP
G
KW
FU
PM C
E
AL
B
FM
C
AS
EC
EM
XL
U
SC
BN
U
VR
Median: 21%Median: 15%
2022 EBITDA MARGINS VS.